Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat
暂无分享，去创建一个
A. Califano | M. Maurer | D. Hershman | J. Yu | K. Crew | C. Chiuzan | M. Onishi | K. Kalinsky | M. Álvarez | M. Trivedi | M. Accordino | K. Fenn | S. Jones | M. Yang | T. Zeleke | E. Honan | S. Kelly | R. Wu | Q. Pan | P. Mukhopadhyay | P. L. Chia | J. Silva